Zobrazeno 1 - 10
of 25
pro vyhledávání: '"Songchen Zhao"'
Autor:
Xintong Hu, Jiandong Tai, Zhihui Qu, Songchen Zhao, Li Zhang, Man Li, Xiguang Sun, Yanfang Jiang
Publikováno v:
PLoS ONE, Vol 11, Iss 3, p e0152368 (2016)
BACKGROUND:Henoch-Schoenlein purpura is the one of most common types of systemic vasculitis that involves impaired renal function and Henoch-Schoenlein purpura nephritis (HSPN). The diagnosis of this condition is largely based on immunohistologic det
Externí odkaz:
https://doaj.org/article/72a02d38f7914dc39764ec4492683ee7
Publikováno v:
PLoS ONE, Vol 10, Iss 7, p e0134523 (2015)
This study is aimed at examining the potential roles of circulating memory T follicular helper (Tfh) cells in patients with multiple sclerosis (MS).The numbers of different subsets of circulating memory Tfh cells in 25 patients with relapsed MS befor
Externí odkaz:
https://doaj.org/article/1f1fbba37f9e4102b487751a5ebdf8a9
Autor:
Zihua Zou, Yangchun Gu, Li Liang, Xuezhi Hao, Chengjuan Fan, Tao Xin, Songchen Zhao, Ziling Liu, Ye Guo, Kewei Ma, Haojing Li, Cuiying Zhang, Li Shan, Yan Zhang, Guilan Dong, Yumei Peng, Fangfang Shen, Xia Song, Petros Christopoulos, Anthonie J. van der Wekken, Katsuhiro Okuda, Simon Ekman, Puyuan Xing, Junling Li
Publikováno v:
Translational lung cancer research, 11(12), 2495-2506. AME PUBL CO
Background: Tyrosine kinase inhibitors (TKIs) have been a major advance in the treatment of anaplastic lymphoma kinase (ALK)-positive non-small cell lung cancer (NSCLC) which have been substantiated in clinical trials. However, real-world data on fir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30898bbd6d1ba5932a471348ed8b5294
https://doi.org/10.21037/tlcr-22-803
https://doi.org/10.21037/tlcr-22-803
Autor:
Jingyuan Yu, Lijuan Qi, Songchen Zhao, Xiaojun Zhang, Xudong Shang, Xintong Hu, Liguo Chen, Duo Wang, Yanfang Jiang, Yan Du
Publikováno v:
Analysis & Sensing.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a3bc7ee0f6edcfb1fa94eeefa8aaa4f9
https://doi.org/10.1002/anse.202300011
https://doi.org/10.1002/anse.202300011
Publikováno v:
Cancer Immunology, Immunotherapy. 69:2547-2560
There are significant differences in pathology, etiology, clinical features, and treatment options between small cell lung cancer (SCLC) and non-small cell lung cancer (NSCLC). However, the differences of macrophage distribution and its associated fu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::51808f5c975fda91403fc49bf5368c47
https://doi.org/10.1007/s00262-020-02639-z
https://doi.org/10.1007/s00262-020-02639-z
Publikováno v:
World Journal of Clinical Cases. 8:54-67
BACKGROUND: Distant metastasis, particularly visceral metastasis (VM), represents an important negative prognostic factor for prostate cancer (PCa) patients. However, due to the lower rate of occurrence of VM, studies on these patients are relatively
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e7b89e498d108596836a721c42eab57
https://doi.org/10.12998/wjcc.v8.i1.54
https://doi.org/10.12998/wjcc.v8.i1.54
Autor:
Songchen Zhao, Xintong Hu, Peiwen Zhou, Ang Li, Liguo Chen, Duo Wang, Jiaxue He, Yanfang Jiang
Publikováno v:
Cancer Biology & Therapy; 2023, Vol. 24 Issue 1, p1-11, 11p
Publikováno v:
Clinical and Experimental Pharmacology and Physiology. 46:1074-1083
The present study was designed to evaluate the percentage of different programmed cell death-1 (PD-1)+ T cell subsets in peripheral blood and bronchoalveolar lavage fluid (BALF) of small cell lung cancer (SCLC) patients. The percentages of PD-1+ T ce
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::41b5b0f737accaf7306953b922739070
https://doi.org/10.1111/1440-1681.13153
https://doi.org/10.1111/1440-1681.13153
Publikováno v:
Cancer Biotherapy and Radiopharmaceuticals. 34:325-333
Purpose: CD4+CD25+Foxp3+ regulatory T (Treg) cell-mediated immunosuppression has been implicated as a crucial mechanism of tumor immune cell escape in nonsmall cell lung cancer (NSCLC). However, little is known concerning the specific role of CD4+CD2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::7b55fb4bd10cedebb0145a58fe3dad21
https://doi.org/10.1089/cbr.2018.2672
https://doi.org/10.1089/cbr.2018.2672
Publikováno v:
Medicine
Rationale: Approximately 20% of patients with non-small cell lung cancer (NSCLC) are diagnosed with brain metastasis, which is related to poor survival outcomes. The ability of tyrosine kinase inhibitor drugs to penetrate the blood–brain barrier ma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ad131c404807099ebbdc896cc3e7e2c2
https://pubmed.ncbi.nlm.nih.gov/34397694
https://pubmed.ncbi.nlm.nih.gov/34397694